With Cipla turning healthy post Q1 results, analysts increase target price
Share prices of Cipla gained almost 12 per cent in intra-day deal on Monday, after the pharma major posted strong quarterly results. After hitting a fresh 52-week high of 814.45 in intra-day deal, the stock closed with a gain of 9.20 per cent at 795.65 on the BSE.
Cipla reported a 26.528 per cent y-o-y growth in its Q1 FY21 consolidated profit at 566.04 crore, thanks to strong performance across its geographies. Revenue from operations grew 9 per cent to 4,346.2 crore.